Browse our collection of papers in
GlaxoSmithKline (GSK)

Select number of records per page:  

C/F/1281. Financial analysis of GlaxoSmithKline and Phytopharm Plc between the years 2008-2010

WORDS:
2650
DATE:
2011
PRICE:
29.99 GBP

This paper performs a financial analysis of two pharmaceutical companies, GlaxoSmithKline (GSK) and Phytopharm Plc. The company’s financial data is examined between the periods of 2008-2010. The paper looks at a variety of ratios, some of which include the quick ratio, the gearing ratio, and the inventory ratio. Both companies’ annual reports are examined, and the paper then evaluates the findings.

 

KEYWORDS: Financial analysis, pharmaceutical, GlaxoSmithKline, Phytopharm Plc, quick ratio, the gearing ratio, inventory ratio,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/F/1204. Financial analysis of GlaxoSmithKline and AstraZeneca

WORDS:
2600
DATE:
2011
PRICE:
29.99 GBP

The paper examines the financial performance of two pharmaceutical companies, GlaxoSmithKline (GSK) and AstraZeneca (AZN) conducting their ratio analysis for 2009 and comparing their financial indices on the basis of the analysis. Recommendations are suggested to the companies’ management and investors.

 

KEYWORDS: Financial analysis, financial ratios, GlaxoSmithKline, GSK, AstraZeneca, AZN,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/M/2173. The reasons why the study of organisations is important

WORDS:
650
DATE:
2011
PRICE:
9.99 GBP

This paper discuses the reasons why studying organisations is important. The paper introduces the concept of organisations, and follows with a discussion regarding management theories. Some of the theories discussed include enterprise architecture and the agency theory. The paper examines aspects regarding GlaxoSmithKline and The Cooperative and concludes with the writers personal opinions on the subject.

 

KEYWORDS: Organisations, management theories, enterprise architecture, agency theory, GlaxoSmithKline, The Cooperative,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

S/F/288. Financial report on GlaxoSmithKline

WORDS:
1500
DATE:
2011
PRICE:
19.99 GBP

The paper presents financial analysis of GlaxoSmithKline (GSK) for 2006-2009 describing the profile of the company, reporting on their financial performance during 2009, and conducting analysis of their financial ratios for 2006-2008. GSK performance is compared to that of Johnson & Johnson (J&J), the main competitor of GSK, suggesting investment in GSK.

 

KEYWORDS: Financial report, GlaxoSmithKline, GSK, Johnson & Johnson, J&J,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/B/3482. SWOT analysis of Aquafresh

WORDS:
1200
DATE:
2011
PRICE:
19.99 GBP

This paper evaluates Aquafresh, using a detailed SWOT analysis. This analysis is conducted to audit Aquafresh and its environment, and focuses on the strengths, weaknesses, opportunities and threats of Aquafresh.

 

KEYWORDS: SWOT, TOWS, Aquafresh,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/B/3473. PESTEL analysis of Aquafresh

WORDS:
1050
DATE:
2011
PRICE:
19.99 GBP

This paper presents an overview of Aquafresh using PESTEL analysis, which identifies the Political, Economic, Social, Technological, Environmental and Legal factors affecting Aquafresh.

 

KEYWORDS: PEST, PESTEL, PESTLE, Aquafresh,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/M/1921. Marketing Mix for Aquafresh

WORDS:
1200
DATE:
2011
PRICE:
19.99 GBP

This paper presents a detailed marketing mix for Aquafresh, and the paper begins by providing the background to the company. The four P’s of marketing are assessed in reference to the organization, namely Product, Price, Place, and Promotion

 

KEYWORDS: Marketing mix, Aquafresh, Product, Price, Place, Promotion,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/F/1004. Financial analysis of GlaxoSmithKline

WORDS:
1300
ADD-ONS:
Excel Data
DATE:
2011
PRICE:
19.99 GBP

This paper evaluates the financial performance of GlaxoSmithKline, focusing on their performance for the financial years 2007-2009. The paper presents an overview of GlaxoSmithKline followed by the analysis of suitable financial ratios of GlaxoSmithKline including interest ratios, gearing ratios, and current ratios. The second part of this paper provides a comprehensive analysis of share performance of GlaxoSmithKline and forecast of share performance for the next 12 months. All calculations are provided in the appendix.

 

KEYWORDS: Financial Analysis, Share Performance, Financial Ratios, GlaxoSmithKline,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/M/1831. Strategic analysis of Aquafresh

WORDS:
3400
DATE:
2010
PRICE:
39.99 GBP

This paper aims to examine the toothpaste Aquafresh, as well as discussing the toothpaste industry in general. The paper begins by providing the background to the company and their products, and this is then followed by a SWOT analysis. The company’s competitive edge is discussed, and the paper then performs a PESTEL analysis. Recommendations for future improvement are suggested in relation to segmentation, targeting and positioning. The main marketing objectives and goals are identified through the SMART framework, and the paper also provides the marketing mix for the company. Conclusions are made regarding the success of the company.

 

KEYWORDS: Toothpaste, Aquafresh, toothpaste industry, SWOT, PESTEL, competitors, segmentation, targeting, positioning, SMART framework, marketing mix,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/F/973. Credit Rating Analysis of GlaxoSmithKline

WORDS:
1600
DATE:
2010
PRICE:
19.99 GBP

The paper looks at the rating agencies that provide ratings on credit worthiness of companies. The relevance of the rating industry is examined discussing the fairness and accuracy of the ratings. A case study is conducted comparing credit rating analysis of GlaxoSmithKline (GSK) given by the two rating agencies on the basis of the company’s financial ratios. Financial risks embedded in the GSK profile are defined, financial challenges of the pharmaceutical industry are discussed.

 

KEYWORDS: Credit Rating, rating agency, GlaxoSmithKline, GSK, financial ratios,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/B/3259. Strategic capability of GlaxoSmithKline

WORDS:
1300
DATE:
2010
PRICE:
19.99 GBP

The paper examines the sources of competitive advantage used by GlaxoSmithKline (GSK) identifying their core competences and capabilities, analyzing the company’s product development strategy using the Ansoff matrix, and categorizing GSK stakeholders on the basis of the Mendelow matrix.

 

KEYWORDS: Strategic capability, GlaxoSmithKline, GSK, Competitive Advantage, Ansoff Matrix, Mendelow Matrix,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/OM/271. Operational management in GlaxoSmithKline

WORDS:
4000
DATE:
2010
PRICE:
49.99 GBP

This paper analyses the practical issues faced by firms from operational perspectives, providing key recommendations for improvement. GlaxoSmithKline (GSK) is used as a case study for research and development (R&D). Operations management in the Pharmaceutical industry is discussed, followed by an overview of GSK. Operational strategy, issues within the R&D Department, operational change, R&D Process mapping, and key performance objectives are discussed. The paper concludes with recommendations and conclusions.

 

KEYWORDS: GlaxoSmithKline, GSK, research and development, R&D, Operations Management,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/F/815. Use of CAPM in measuring investment opportunities of M&S and GSK

WORDS:
2250
DATE:
2010
PRICE:
29.99 GBP

The paper looks at the corporate and international financial measures used to minimise risks associated with investment decisions examining Marks and Spencer (M&S) and GlaxoSmithKline (GSK) as investment opportunities. The use of financial measurement tools includes the calculation and comparison of Beta for the stocks of both companies using the Capital Asset Pricing Model (CAPM).

 

KEYWORDS: Marks and Spencer, M&S, GlaxoSmithKline, GSK, Investment Decisions, Capital Asset Pricing Model, CAMP,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/HR/744. Dissertation. Communication challenges arising from off shoring to India. GSK case study.

WORDS:
13400
DATE:
2010
PRICE:
139.99 GBP

This dissertation looks at the off shoring of US and UK firms to India for selected activities, in particular IT outsourcing. The dissertation is focused on a case study of GlaxoSmithKline (GSK) and the company’s initiative of offshoring part of their activities. The dissertation outlines how offshoring provides a number of benefits to firms such as lowering the cost of services as well as concentrating the skills and capabilities of specific functions in one area, and these benefits are expected to ensure that firms will continue to pursue offshoring as part of their overall strategy. The dissertation addresses the following issues: Understand the communications and training challenges that US and UK firms faced in their transactions with Indian IT vendor personnel, Assess the communications between the US and UK personnel with their India counterparts, and provide recommendations to address the challenges identified in the communications and training related to off shoring of functions. A literature review is followed by the use of conversation analysis (ca) to analyse cross-cultural communications.

 

KEYWORDS: Dissertation, Offshoring, India, GSK, GlaxoSmithKline communication challenges, IT outsourcing, conversation analysis, CA, HRO, human resource outsourcing, international business, international culture, cross cultural,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/M/1543. Disaster and security management: theory and case studies

WORDS:
3550
DATE:
2010
PRICE:
39.99 GBP

The paper looks at the practices of disaster and security management (DSM) examining case studies related to different areas of DSM: the failure of intelligence in business continuity at British Petroleum (BP), the problem of crisis communications in the management of the disaster at Trans World Airlines (TWA) Flight 800, and the incident involving a contaminated toothpaste product in GlaxoSmithKline (GSK).

 

KEYWORDS: Disaster and security management, British Petroleum, crisis communications, Trans World Airlines, GlaxoSmithKline,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/B/2265. Strategic directions of pharmaceutical companies GSK, Pfizer and Novartis

WORDS:
1250
DATE:
2010
PRICE:
19.99 GBP

The paper examines the strategic development of companies operating in the pharmaceutical industry, i.e. GlaxoSmithKline (GSK), Pfizer and Novartis. Key competences, capabilities and resources of GSK are discussed with references to the theory of strategy.

 

KEYWORDS: GlaxoSmithKline, GSK, Pfizer, Novartis, pharmaceutical industry, strategic directions,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/OM/207. Quality management in Shoeshine PLC

WORDS:
1850
DATE:
2010
PRICE:
19.99 GBP

The paper looks at the strategic objectives of operations management (OM) using the examples of GlaxoSmithKline (GSK) and Sainsbury’s, and conducting a case study of OM in Shoeshine PLC. The company’s strategic and organisational objectives are examined suggesting recommendations about the ways to improve organisational performance through cost, time and quality.

 

KEYWORDS: Shoeshine, Sainsbury’s, GlaxoSmithKline, GSK, Operations Management,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/OM/197. Innovation Audit: Use of Molecular Clinical Safety Intelligence System by GlaxoSmithKline

WORDS:
1400
DATE:
2010
PRICE:
19.99 GBP

The paper looks at the Molecular Clinical Safety Intelligence (MCSI), a unique intelligent knowledge management system used by GlaxoSmithKline (GSK) to screen potential candidates and identify possible health issues prior to clinical development. Organisational context of GSK is described, their investment in innovative technologies is discussed, the importance of MCSI system for the development of new drugs is highlighted.

 

KEYWORDS: Molecular Clinical Safety Intelligence, MCSI, Innovation, GlaxoSmithKline, GSK, Pharmaceutical, new drugs development,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/B/2111. Corporate social responsibility in pharmaceutical industry: case study of GlaxoSmithKline

WORDS:
1000
DATE:
2010
PRICE:
19.99 GBP

The paper describes the environment of the pharmaceutical industry highlighting its challenges and threats, addressing the issues of corporate social responsibility (CSR) faced by pharmaceutical companies, and examining the mission of GlaxoSmithKline (GSK) with regard to their CSR implementation.

 

KEYWORDS: pharmaceutical industry, GlaxoSmithKline, GSK, corporate social responsibility, CSR,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/B/2096. UK healthcare system and strategic issues faced by GlaxoSmithKline

WORDS:
4000
DATE:
2010
PRICE:
49.99 GBP

The paper looks at the challenges facing the companies that operate within the UK healthcare system presenting a case study of the pharmaceutical company GlaxoSmithKline (GSK). The business environment of the UK healthcare system and national health service (NHS) is analysed, SWOT analysis of GSK is conducted, scenarios for the company development are considered, the role of leadership and governance in GSK change management is evaluated.

 

KEYWORDS: GSK, GlaxoSmithKline, UK Healthcare, National Health Services, NHS, Pharmaceutical,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/N/297. GlaxoSmithKline (GSK) and Production of Swine Flu Vaccines

WORDS:
2800
DATE:
2009
PRICE:
29.99 GBP

The paper addresses the issue of combating the global flu epidemic of Swine flu (H1N1) using a case study of the GSK vaccine unit. Analysis is conducted of the production of regular and swine flu vaccines using the PESTEL model, pharmaceutical industry life cycle analysis, Porter’s Five Forces and SWOT analysis of the GSK vaccine unit, analysis of the unique resources of the GSK vaccine unit, etc. The risk of dividing production between regular vaccine and swine flu vaccine is discussed suggesting the production of both regular and swine flu vaccines by GSK’s vaccine unit.

 

KEYWORDS: GlaxoSmithKline, GSK, Swine Flu Vaccines, SWOT, Porter’s five forces, PESTEL, Value Chain,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/F/560. Strategic Financial Analysis of AstraZeneca and GlaxoSmithKline

WORDS:
3100
DATE:
2009
PRICE:
39.99 GBP

The paper examines the factors that affected the financial performance of AstraZeneca (AZN) and GlaxoSmithKline (GSK) giving particular focus to the analysis of the product portfolio and recent developments in the pharmaceutical industry. An overview of the companies’ ratios over 2004-2008 is provided suggesting recommendations for the investors.

 

KEYWORDS: GlaxoSmithKline, GSK, AstraZeneca, AZN, pharmaceutical industry,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

S/B/510. Dissertation. Impact of newspaper publicity on social and environmental disclosures in annual reports

WORDS:
13800
DATE:
2009
PRICE:
139.99 GBP

The dissertation explores the outcomes of negative publicity received through newspaper articles on companies' disclosure levels. Literature is reviewed on the role of the media in shaping society attitudes reporting on the MNC exposed by the media, i.e. Cadbury Schweppes, GlaxoSmithKline, Royal Dutch Shell and Tesco. Content analysis is used as a preferred research methods, the relevance of newspaper articles for companies' exposure is studied. Conclusions are made about companies' responses to positive and negative media publicity.

 

KEYWORDS: Dissertation, disclosure, negative publicity, legitimacy, annual report, climate change,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/F/416. Financial Performance Analysis: GSK vs. Johnson and Johnson

WORDS:
2600
DATE:
2009
PRICE:
29.99 GBP

This report looks at Financial Structure of two pharmaceutical companies i.e. GlaxoSmithKline and Johnson & Johnson. It examines the fiscal fitness of the company with the help of different financial ratios for 2003-2007 years. For each company five year financial data has been analyzed to check the overall performance of the company. Moving forward to check the corporate responsibility, share performance of the company has been diagnosed by way of dividend and earnings per share. Finally, financial performance of both the companies is compared to each other.

 

KEYWORDS: f, financial, performance, analysis, gsk, vs, johnson, johnson,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

C/B/1158. Dissertation. Management Analysis of GlaxoSmithKline

WORDS:
10600
DATE:
2008
PRICE:
109.99 GBP

The dissertation addresses the issues of strategic management in the world leading pharmaceutical company GlaxoSmithKline (GSK). Customer, industry and competitor analysis of the pharmaceutical industry is presented, the background of GSK is described, their core values, resources, competences and strategic competitiveness are defined conducting SWOT, Porter's Generic Strategies and value chain analysis. Growth strategies related to their market and product development are identified and evaluated. Recommendations are suggested about the strategies towards the existing and new markets and products.

 

KEYWORDS: dissertation, management, glaxosmithkline,

DOWNLOAD THIS PAPER DOWNLOAD THE REFERENCE LIST

 

CUSTOM WRITING

Can't find what you are looking for? Click here to order a custom written paper

Subject Catalogue

GET OUR GooGLE TOOLBAR BUTTON
Click here
BOOK MARK US
WHAT OTHERS
HAVE SAID
Great service I would highly recommend your site to my friends. Thank You! Nicole